vs
Grove Collaborative Holdings, Inc.（GROV）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Grove Collaborative Holdings, Inc.的1.8倍（$75.5M vs $42.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -14.3%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-62.0K），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -11.0%）
Grove Collaborative控股公司是一家公益企业，总部位于美国旧金山，在缅因州波特兰设有额外办事处。该企业以自有品牌Grove Co.推出并销售自有环保家居及个人护理产品，同时也代理销售其他品牌的相关产品，主打绿色可持续的日用消费品类目。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GROV vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$42.4M
营收增速更快
PBYI
高出42.0%
-14.3%
自由现金流更多
PBYI
多$14.4M
$-62.0K
两年增速更快
PBYI
近两年复合增速
-11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.4M | $75.5M |
| 净利润 | $-1.6M | — |
| 毛利率 | 53.0% | 69.3% |
| 营业利润率 | -3.7% | 22.7% |
| 净利率 | -3.7% | — |
| 营收同比 | -14.3% | 27.7% |
| 净利润同比 | 87.5% | — |
| 每股收益（稀释后） | $-0.06 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GROVPBYI
| Q4 25 | $42.4M | $75.5M | ||
| Q3 25 | $43.7M | $54.5M | ||
| Q2 25 | $44.0M | $52.4M | ||
| Q1 25 | $43.5M | $46.0M | ||
| Q4 24 | $49.5M | $59.1M | ||
| Q3 24 | $48.3M | $80.5M | ||
| Q2 24 | $52.1M | $47.1M | ||
| Q1 24 | $53.5M | $43.8M |
净利润GROVPBYI
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-3.0M | $8.8M | ||
| Q2 25 | $-3.6M | $5.9M | ||
| Q1 25 | $-3.5M | $3.0M | ||
| Q4 24 | $-12.6M | — | ||
| Q3 24 | $-1.3M | $20.3M | ||
| Q2 24 | $-10.1M | $-4.5M | ||
| Q1 24 | $-3.4M | $-4.8M |
毛利率GROVPBYI
| Q4 25 | 53.0% | 69.3% | ||
| Q3 25 | 53.3% | 77.7% | ||
| Q2 25 | 55.4% | 76.5% | ||
| Q1 25 | 53.0% | 77.1% | ||
| Q4 24 | 52.4% | 76.4% | ||
| Q3 24 | 53.0% | 63.9% | ||
| Q2 24 | 53.9% | 77.4% | ||
| Q1 24 | 55.5% | 75.5% |
营业利润率GROVPBYI
| Q4 25 | -3.7% | 22.7% | ||
| Q3 25 | -6.2% | 17.6% | ||
| Q2 25 | -7.9% | 12.7% | ||
| Q1 25 | -8.1% | 8.7% | ||
| Q4 24 | -16.8% | 22.6% | ||
| Q3 24 | -14.0% | 27.4% | ||
| Q2 24 | -13.3% | -4.6% | ||
| Q1 24 | -1.0% | -5.3% |
净利率GROVPBYI
| Q4 25 | -3.7% | — | ||
| Q3 25 | -6.8% | 16.2% | ||
| Q2 25 | -8.2% | 11.2% | ||
| Q1 25 | -8.1% | 6.5% | ||
| Q4 24 | -25.5% | — | ||
| Q3 24 | -2.8% | 25.2% | ||
| Q2 24 | -19.3% | -9.6% | ||
| Q1 24 | -6.3% | -11.0% |
每股收益（稀释后）GROVPBYI
| Q4 25 | $-0.06 | $0.26 | ||
| Q3 25 | $-0.08 | $0.17 | ||
| Q2 25 | $-0.10 | $0.12 | ||
| Q1 25 | $-0.10 | $0.06 | ||
| Q4 24 | $-0.34 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $-0.28 | $-0.09 | ||
| Q1 24 | $-0.10 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-17.0M | $130.3M |
| 总资产 | $53.1M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GROVPBYI
| Q4 25 | $8.5M | $97.5M | ||
| Q3 25 | $8.9M | $94.4M | ||
| Q2 25 | $10.0M | $96.0M | ||
| Q1 25 | $9.6M | $93.2M | ||
| Q4 24 | $19.6M | $101.0M | ||
| Q3 24 | $50.8M | $96.7M | ||
| Q2 24 | $78.8M | $96.8M | ||
| Q1 24 | $77.8M | $107.2M |
总债务GROVPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $32.2M | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GROVPBYI
| Q4 25 | $-17.0M | $130.3M | ||
| Q3 25 | $-16.1M | $115.3M | ||
| Q2 25 | $-14.0M | $104.7M | ||
| Q1 25 | $-11.6M | $97.1M | ||
| Q4 24 | $-8.5M | $92.1M | ||
| Q3 24 | $1.5M | $71.1M | ||
| Q2 24 | $686.0K | $48.5M | ||
| Q1 24 | $7.5M | $51.0M |
总资产GROVPBYI
| Q4 25 | $53.1M | $216.3M | ||
| Q3 25 | $54.6M | $202.9M | ||
| Q2 25 | $57.8M | $194.9M | ||
| Q1 25 | $59.8M | $196.2M | ||
| Q4 24 | $65.0M | $213.3M | ||
| Q3 24 | $105.2M | $220.7M | ||
| Q2 24 | $131.8M | $205.0M | ||
| Q1 24 | $137.9M | $214.1M |
负债/权益比GROVPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 21.16× | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-62.0K | $14.4M |
| 自由现金流率自由现金流/营收 | -0.1% | 19.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流GROVPBYI
| Q4 25 | $-29.0K | $14.4M | ||
| Q3 25 | $-1.0M | $9.7M | ||
| Q2 25 | $987.0K | $14.1M | ||
| Q1 25 | $-6.9M | $3.6M | ||
| Q4 24 | $270.0K | $15.6M | ||
| Q3 24 | $750.0K | $11.0M | ||
| Q2 24 | $1.6M | $1.0M | ||
| Q1 24 | $-12.4M | $11.2M |
自由现金流GROVPBYI
| Q4 25 | $-62.0K | $14.4M | ||
| Q3 25 | $-1.2M | $9.7M | ||
| Q2 25 | $556.0K | $14.1M | ||
| Q1 25 | $-7.4M | $3.6M | ||
| Q4 24 | $-95.0K | $15.6M | ||
| Q3 24 | $264.0K | $11.0M | ||
| Q2 24 | $1.2M | $1.0M | ||
| Q1 24 | $-12.9M | — |
自由现金流率GROVPBYI
| Q4 25 | -0.1% | 19.1% | ||
| Q3 25 | -2.7% | 17.7% | ||
| Q2 25 | 1.3% | 26.8% | ||
| Q1 25 | -17.0% | 7.7% | ||
| Q4 24 | -0.2% | 26.4% | ||
| Q3 24 | 0.5% | 13.7% | ||
| Q2 24 | 2.3% | 2.1% | ||
| Q1 24 | -24.1% | — |
资本支出强度GROVPBYI
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 1.2% | 0.1% | ||
| Q4 24 | 0.7% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
现金转化率GROVPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GROV
| Third Party Products | $23.4M | 55% |
| Grove Brands | $19.0M | 45% |
PBYI
暂无分部数据
